IPO Traffic: Week Ending July 4, 2014

  Lead Manager/ # of Price Range   Dollar SCOOP
New Filings (Proposed Symbol) Joint-Lead Managers Shares Low High Volume Ratings
Albéa S.A. (TBA) BofA Merrill Lynch/ J.P. Morgan/ Goldman Sachs     $150.00 n.a.
Auris Medical Holding AG  (EARS) Jefferies/ Leerink Partners       $86.25 n.a.
Avalanche Biotechnologies (AAVL) Jefferies/ Cowen and Company/ Piper Jaffray     $86.25 n.a.
Diplomat Pharmacy  (TBA) Credit Suisse/ Morgan Stanley/ J.P. Morgan/ Wells Fargo Securities/ William Blair/ Leerink Partners $100.00 n.a.
DT Asia Investments Ltd  (CADTU) (u) EarlyBirdCapital 6.00 $10.00 $10.00 $60.00 n.a.
Expro Oilfield Services PLC (TBA) TBA       $100.00 n.a.
Hoegh LNG Partners LP (TBA) Citigroup/ BofA Merrill Lynch/ Morgan Stanley     $100.00 n.a.
iDreamSky Technology (DSKY) Credit Suisse/ J.P. Morgan       $115.00 n.a.
Loxo Oncology (LOXO) Cowen and Company/ Stifel       $69.00 n.a.
OM Asset Management Ltd (OMAM) BofA Merrill Lynch/ Morgan Stanley/ Citigroup/ Credit Suisse   $100.00 n.a.
T2 Biosystems (TTOO) Goldman Sachs/ Morgan Stanley       $69.00 n.a.
Viamet Pharmaceuticals (VIAM) Piper Jaffray/ Stifel/ Wells Fargo Securities     $86.25 n.a.
Viking Therapeutics (VKTX) Oppenheimer/ Roth Capital Partners       $57.50 n.a.
Yodlee  (YDLE) Goldman Sachs/ Credit Suisse/ BofA Merrill Lynch   $75.00 n.a.
Zayo Group Holdings (TBA) Morgan Stanley/ Barclays/ Goldman Sachs     $100.00 n.a.
n.a. (not available)            
             
Postponed            
None            
             
Withdrawn            
Ambrx  (AMBX) Stifel/ Wells Fargo Securities 5.40 $12.00 $14.00 $86.25 2-Stars
Gates Global (TBA) BofA Merrill Lynch/ Citigroup/ Goldman Sachs/ Barclays/ Credit Suisse/ J.P. Morgan/ RBC Capital Markets $100.00 n.a.
Transport America  (TRAM) Baird/ Stifel       $75.00 n.a.
Taggares Agriculture  (TAG) Janney Montgomery Scott/ ROTH Capital Partners 7.00 $6.00 $7.00 $45.50 1-Star
             
New Terms            
ContraFect (CFRXU) (u) Maxim Group LLC 3.64 $5.00 $6.00 $20.00 n.a.
GlobeImmune  (GBIM) Aegis Capital Corp. 1.00 $15.00 $15.00 $15.00 1-Star
Microlin Bio (MCLB) Brean Capital/ Sunrise Securities 5.50 $4.50 $5.50 $27.50 1-Star
Minerva Neurosciences (NERV) Jefferies 5.45 $6.00 $6.00 $32.73 1-Star
TerraForm Power (TERP) Goldman Sachs/Barclays/ Citigroup/J.P. Morgan/ Macquarie Capital $550.00 n.a.
Westlake Chemical Partners LP  (WLKP) Barclays/ UBS Investment Bank/ BofA Merrill Lynch/ Deutsche Bank Securities/ Morgan Stanley $271.69 n.a.
n.a. (not available)            
u (unit offering)            
             
IPOs Priced Lead Shares Amount Offer Close %
Week of June 30, 2014 Manager(s) Offered Raised Price 7/3/14 Change
GlobeImmune  (GBIM) Aegis Capital Corp. 1.50 $15.00 $10.00 $11.85 18.50%
Minerva Neurosciences (NERV) Jefferies 5.45 $32.73 $6.00 $6.13 2.17%
Investar Holding  (ISTR) Sandler O’Neill + Partners/ Sterne Agee 2.88 $40.25 $14.00 $14.05 0.36%

The IPO Buzz: A Little Banking Before the 4th

This week’s newcomer is a banking company with Louisiana roots:  
 
Investar Holding (ISTRproposed) is a Baton Rouge, Louisiana-based bank holding company formed in 2006. Investar offers a wide range of commercial banking products tailored to meet the needs of individuals and small to medium-sized businesses. In addition to its Baton Rouge headquarters, the bank offers services from nine other full-service branches throughout the state. (For more information, please click here: Investar Holding)
 
The deal is expected to be priced Monday evening, June 30, to start trading Tuesday, July 1st. This kicks off the second half of 2014.
 
First Six Months of 2014
Let’s take a look back at the first half of this year.
 
On Friday, June 27, 2014:
IPOs priced: 142
Up: 93
Down: 49
Average gain: 18.3 percent.
NADSAQ Composite Index: UP 5.3 percent
 
(The IPO numbers are according to the U.S. Securities and Exchange Commission filings. Excluded are unit offerings consisting of common stock and warrants, closed-end investment companies, bank conversions and foreign companies offering American Depositary Shares that represent shares of stock already trading on their local stock exchanges.)
 
The Hero – 2014 Mid-year:
Enerous (WATT) is a Baton Rouge, Louisiana-based development stage technology company working to develop technology that can enable wireless charging or powering of electronic devices at a distance. On March 27, 2014, the company priced its IPO of 4 million shares at $6 each. It closed Friday, June 27 at $15.50, UP 158.3 percent from its initial offering price. 
 
The Goat – 2014 Mid-year:
NephroGenex (NRX) is a Research Triangle Park, North Carolina-based pharmaceutical company focused on the development of therapeutics to treat kidney disease. On Feb. 10, 2014, the company priced its IPO of 3.1 million shares at $12 each. It closed Friday at $5.95, DOWN 50.4 percent from its initial offering price.
 
2013’s First Half in Review
Now let’s take a look further back to 2013’s first half.
 
On Friday, June 28, 2013:
IPOs priced: 91
Up: 65
Down: 24
Unchanged: 2
Average gain: 23.7 percent.
NADSAQ Composite Index: UP 12.7 percent
 
 
The Hero – 2013 Mid-year:
ExOne (XONE) is a North Huntingdon, Pennsylvania-based provider of three-dimensional printing machines and printed products to industrial customers. On Feb. 6, 2013, the company priced its IPO of 5.3 million shares at $18 each. It closed Friday, June 28, 2013, at $61.72, UP 242.9 percent from its initial offering price. Fast forward to Friday, June 27, 2014, ExOne closed at $37.59, DOWN 39.1 percent from a year ago, but UP 108.8 percent from its initial offering price.
 
The Goat – 2013 Mid-year:
Professional Diversity Network (IPDN) is a Chicago-based provider of online networks serving diverse professionals in the United States The company focuses on Hispanic and African-American professionals. On March 5, 2013, the company priced its IPO of 8 million shares at $8 each. It closed Friday, June 28, 2013, at $4.19, DOWN 47.6 percent from its initial offering price. Fast forward to Friday, June 27, 2014, it closed at $4, DOWN 50 percent from a year ago. 
 
Looking into the week of July 7, the calendar has only one IPO. But anything could happen. July will still be young.
 
Stay tuned.
 
 
Disclosure: Neither the author nor anyone else on the IPOScoop.com staff has a position in any stocks mentioned, nor do we trade or invest in IPOs. The author and IPOScoop.com staff do not issue advice, recommendations or opinions.
 
 

IPO Traffic: Week Ending June 27, 2014

  Lead Manager/ # of Price Range   Dollar SCOOP
New Filings (Proposed Symbol) Joint-Lead Managers Shares Low High Volume Ratings
Affimed Therapeutics B.V. (AFMD) Jefferies/ Leerink Partners/ BMO Capital Markets     $75.00 n.a.
Cyber-Ark Software (CYBR) J.P. Morgan/ Deutsche Bank Securities/ Barclays   $75.00 n.a.
El Pollo Loco Holdings  (LOCO ) Jefferies/ Morgan Stanley/ Baird       $100.00 n.a.
Green Bancorp (GNBC) SANDLER O’NEILL + PARTNERS/ Jefferies     $100.00 n.a.
Immune Design (IMDZ) Jefferies/ Leerink Partners       $60.00 n.a.
Intersect ENT (XENT) J.P. Morgan/ Piper Jaffray       $80.00 n.a.
Lantheus Holdings (LNTH) Citigroup/ Jefferies       $125.00 n.a.
Macrocure (MCUR) Credit Suisse/ Jefferies       $75.00 n.a.
rEVO Biologics (RBIO) Piper Jaffray/ Guggenheim Securities       $74.75 n.a.
Terrapin 3 Acquisition (TRTLU) Deutsche Bank Securities 18.50 $10.00 $10.00 $185.00 n.a.
Tobira Therapeutics (TBRA) BMO Capital Markets/ JMP Securities/ Oppenheimer   $69.00 n.a.
Townsquare Media (TSQ) BofA Merrill Lynch/ Jefferies/ RBC Capital Markets   $143.75 n.a.
Transocean Partners  (RIGP) Morgan Stanley/ Barclay       $350.00 n.a.
Univar (UNVR) Deutsche Bank Securities/ Goldman Sachs/ BofA Merrill Lynch   $100.00 n.a.
VWR Corp (TBA) BofA Merrill Lynch/ Goldman Sach/ J.P. Morgan     $100.00 n.a.
Woodside Homes (WDS) Credit Suisse/ J.P. Morgan/ Deutsche Bank Securities   $200.00 n.a.
Zosano Pharma (ZSAN) Wedbush PacGrow Life Sciences       $65.00 n.a.
n.a. (not available)            
             
Postponed            
Syndax Pharmaceuticals (SNDX) Deutsche Bank Securities/ Jefferies 4.30 $13.00 $15.00 $60.20 1-Star
             
Withdrawn            
None            
             
New Terms            
NextEra Energy Partners, LP  (NEP) BofA Merrill Lynch/ Goldman Sachs/ Morgan Stanley 16.25 $23.00 $25.00 $390.00 3-Stars
Microlin Bio (MCLB) Brean Capital/ Sunrise Securities 6.00 $4.50 $5.50 $30.00 1-Star
Good Technology   (GDTC) Morgan Stanley/ Barclays/ BofA Merrill Lynch/ Citigroup   $100.00 n.a.
Alibaba Group Holding  (BABA) Credit Suisse/ Deutsche Bank Securities/ Goldman Sachs/ J.P. Morgan/ Morgan Stanley/ Citi $1,000.00 n.a.
n.a. (not available)            
             
IPOs Priced Lead Shares Amount Offer Close %
Week of June 23, 2014 Manager(s) Offered Raised Price 6/27/14 Change
Adeptus Health  (ADPT) Deutsche Bank Securities/ Goldman Sachs 4.90 $107.80 $22.00 $35.76 62.55%
Amphastar Pharmaceuticals  (AMPH) Jefferies/ BMO Capital Markets/ Piper Jaffray 8.00 $56.00 $7.00 $10.50 50.00%
GoPro   (GPRO) J.P. Morgan/ Citigroup/ Barclays 17.80 $427.20 $24.00 $35.76 49.00%
NextEra Energy Partners, LP  (NEP) BofA Merrill Lynch/ Goldman Sachs/ Morgan Stanley 16.25 $406.25 $25.00 $32.00 28.00%
Xunlei Limited (XNET) J.P. Morgan/ Citigroup 7.32 $87.78 $12.00 $15.09 25.75%
ServiceMaster Global Holdings  (SERV) J.P. Morgan/ Credit Suisse/ Goldman Sachs/ Morgan Stanley 35.90 $610.30 $17.00 $18.75 10.29%
Imprivata  (IMPR) J.P. Morgan/ Piper Jaffray 5.00 $75.00 $15.00 $16.22 8.13%
Moko Social Media Ltd  (MOKO) Northland Capital Markets 1.10 $8.25 $7.50 $7.70 2.67%
Michaels Companies  (The) (MIK) J.P. Morgan/ Goldman Sachs/ Barclays/ Deutsche Bank Securities 27.78 $472.22 $17.00 $17.02 0.12%
Garnero Group Acquisition (GGACU) (u) EarlyBirdCapital 12.50 $10.00 $10.00 $10.00 0.00%
Materialise NV (MTLS) Piper Jaffray/ Credit Suisse 8.00 $96.00 $12.00 $11.92 -0.67%
TCP International Holdings Ltd.  (TCPI) Deutsche Bank Securities/ Piper Jaffray 7.14 $78.57 $11.00 $10.18 -7.45%

The IPO Buzz: June’s IPO Heat Wave

The IPO market needs the winds of a bull market at its back to flourish. That’s exactly what’s happening. Two of the three major stock market indexes closed on Friday, June 20, at record  highs. The Dow Jones Industrial Average ended at 16,947.08 and the S&P 500 Index at 1,962.87. The NASDAQ Composite Index finished at a 14-year high at 4,368.04. The last time the NASDAQ closed higher was – you guessed it – during the insanity-dot-com Internet bubble when it ended at 4,446.20 on April 7, 2000.
 
This year’s IPO market, including last week’s pricings and this week’s calendar, can be split into the “haves” and “have-nots.”
 
For the year to date: 131 IPOs have been priced; 84 were winners and 47 were losers. Last week: 11 IPOs were priced; six were winners and five were losers. This tells you that not everything is a slam dunk in the 2014 IPO market. It sets the stage for this week’s calendar of 17 IPOs. It, too, has a few “haves.” And the rest? Well, time will tell.
 
A Handful of “Haves”
Let’s look at five deals that some think could be the “haves.”
 
GoPro (GPROproposed) is a San Mateo, California-based manufacturer of high-definition personal wearable cameras used in action video photography. The cameras are lightweight, rugged, wearable or mountable in unusual places, enabling users to capture, manage, share and enjoy experiences such as rock climbing, surfing and biking. (For more information, please click here: GoPro)   
 
Imprivata (IMPR – proposed) is a Lexington Massachusetts-based provider of authentication and access management technology solutions for the healthcare industry. The company makes the OneSign Platform for securing employee access to desktops, networks and applications. Imprivata services over 1,250 clients and offices in the United States, the United Kingdom, Italy, Belgium, and Germany. The OneSign Platform can be installed on every workstation and other application access points throughout a healthcare organization. It becomes a part of the customer’s security and access infrastructure.  (For more information, please click here: Imprivata)
 
Materialise NV (MTLS – proposed) is a Belgium-based provider of additive manufacturing software known as 3D printing. The company supplies customers in a variety of industries, such as healthcare, automotive, aerospace, art and design, consumer products, financial services, government verticals, the energy/utilities, retail and telecommunications industries. (For more information, please click here: Materialise NV)
 
Michaels Companies (MIK – proposed) is an Irving, Texas-based arts and crafts specialty retailer providing materials, project ideas and education for creative activities. Michaels is a mecca for teachers and do-it-yourself brides. The company operates four regional processing centers in California, Texas, North Carolina and Ontario. It has about 1,260 stores. (For more information, please click here: The Michaels Companies)
 
Xunlei Limited (XNET – proposed) believes it is the 12th-largest Internet company in China. The company delivers digital media content, such as video, music and games to over 300 million monthly unique visitors. Xunlei operates a powerful Internet platform based on cloud computing to let users access, manage, and consume digital media content. (For more information, please click here: Xunlei Limited)
 
Of course, there are other interesting IPOs on this week’s calendar. A couple of those names could emerge on somebody’s “most wanted” list as the week progresses.
 
Looking into the week of June 30, the calendar has only one IPO as it cruises into the July 4th holiday break.
 
Stay tuned.
 
 
Disclosure: Neither the author nor anyone else on the IPOScoop.com staff has a position in any stocks mentioned, nor do we trade or invest in IPOs. The author and IPOScoop.com staff do not issue advice, recommendations or opinions.
 

IPO Traffic: Week Ending June 20, 2014

  Lead Manager/ # of Price Range   Dollar SCOOP
New Filings (Proposed Symbol) Joint-Lead Managers Shares Low High Volume Ratings
Armada Water Assets (AWA) Aegis Capital Corp       $20.00 n.a.
Atara Biotherapeutics (ATRA) Goldman Sachs/ Citigroup       $50.00 n.a.
ATD Corporation   (TBA) BofA Merrill Lynch/ Deutsche Bank Securities/ Goldman Sachs/ Barclays/ J.P. Morgan/ UBS Investment Bank $100.00 n.a.
FCB Financial Holdings (FCB) Deutsche Bank Securities/ J.P. Morgan/ BofA Merrill Lynch   $150.00 n.a.
Independence Contract Drilling  (ICD) Morgan Stanley/ Barclays       $172.50 n.a.
Innocoll GmbH   (INNL) Piper/Jaffray Stifel       $86.25 n.a.
iRadimed  (IRMD) Roth Capital Partners       $11.50 n.a.
Ironshore (IRSH) BofA Merrill Lynch/ UBS Investment Bank     $100.00 n.a.
Mobileye N.V.  (MBLY) Goldman Sachs/ Morgan Stanley       $100.00 n.a.
Ocular Therapeutix  (OCUL) Morgan Stanley/ Cowen and Company/ RBC Capital Markets   $86.25 n.a.
Plymouth Industrial  (PLYM) Sandler O’Neill + Partners, L.P.       $172.50 n.a.
Sage Therapeutics (SAGE) J.P. Morgan/ Goldman Sachs       $69.00 n.a.
Shell Midstream Partners, L.P.  (SHLX) Barclays/ Citigroup       $750.00 n.a.
Smart & Final Stores (SFS) Credit Suisse/ Morgan Stanley/ Deutsche Bank Securities   $100.00 n.a.
Trupanion (TRUP) RBC Capital Markets/ Barclays/ Stifel       $75.00 n.a.
VTTI Energy Partners LP  (VTTI) Citigroup/ J.P. Morgan       $420.00 n.a.
n.a. (not available)            
             
Postponed            
None            
             
Withdrawn            
Energy & Exploration Partners (ENXP) Citigroup       $270.00  
JTH Holding (TAX) Jefferies/ SunTrust Robinson Humphrey     $90.00  
             
New Terms            
Investar Holding  (ISTR) Sandler O’Neill + Partners/ Sterne Agee 2.88 $15.00 $17.00 $46.00 n.a.
Medical Transcription Billing  (MTBC) Chardan Capital Markets/ Aegis Capital Corp/ Summer Street Research Partners 3.00 $9.00 $11.00 $30.00 n.a.
Michaels Companies  (The) (MIK) J.P. Morgan/ Goldman Sachs/ Barclays/ Deutsche Bank Securities 27.78 $17.00 $19.00 $500.00 3-Stars
Microlin Bio (MCLB) Brean Capital/ Sunrise Securities 4.29 $6.50 $7.50 $30.00 1-Star
NextEra Energy Partners, LP  (NEP) BofA Merrill Lynch/ Goldman Sachs/ Morgan Stanley 16.25 $19.00 $21.00 $325.00 2-Stars
ServiceMaster Global Holdings  (SERV) J.P. Morgan/ Credit Suisse/ Goldman Sachs/ Morgan Stanley 35.90 $18.00 $21.00 $700.05 1-Stars
TCP International Holdings Ltd.  (TCPI) Deutsche Bank Securities/ Piper Jaffray 7.14 $13.00 $15.00 $100.00 2-Stars
TerraForm Power (TERP) Goldman Sachs/Barclays/ Citigroup       $50.00 n.a.
             
IPOs Priced Lead Shares Amount Offer Close %
Week of June 16, 2014 Manager(s) Offered Raised Price 6/20/14 Change
Kite Pharma  (KITE) Jefferies/ Credit Suisse/ Cowen and Company 7.50 $127.50 $17.00 $29.00 70.59%
ZS Pharma  (ZSPH) J.P. Morgan/ Credit Suisse 5.94 $107.00 $18.00 $28.50 58.33%
Viper Energy Partners LP (VNOM) Barclays/ Credit Suisse/ Wells Fargo Securities 5.00 $130.00 $26.00 $33.99 30.73%
ZAFGEN (ZFGN) Leerink Partners/ Cowen and Company 6.00 $96.00 $16.00 $19.80 23.75%
Markit Ltd.  (MRKT) BofA Merrill Lynch/ Barclays/ Citigroup/ Credit Suisse/ Deutsche Bank Securities/ Goldman Sachs/ HSBC/ J.P. Morgan/ Morgan Stanley/ UBS Investment Bank 53.47 $1,283.34 $24.00 $26.95 12.29%
Performance Sports Group (PSG) Morgan Stanley/ BofA Merrill Lynch/ RBC Capital Markets 7.10 $110.00 $15.50 $16.65 7.42%
Ardelyx  (ARDX) Citigroup/ Leerink Partners 4.29 $60.00 $14.00 $14.31 2.21%
Foresight Energy LP (FELP) Barclays/ Citigroup/ Morgan Stanley/ J.P. Morgan/ Goldman Sachs/ Deutsche Bank Securities 17.50 $350.00 $20.00 $19.57 -2.15%
Eclipse Resources (ECR) Citigroup/ Goldman Sachs/ Morgan Stanley/ Barclays/ BMO Capital Market/ Deutsche Bank Securities/ KeyBanc Capital Market/ RBC Capital Markets 30.30 $818.10 $27.00 $25.75 -4.63%
Century Communities (CCS) FBR/ J.P. Morgan/ Deutsche Bank Securities 4.45 $102.35 $23.00 $21.00 -8.70%
Parnell Pharmaceuticals Holdings   (PARN) Jefferies/ Piper Jaffray 5.00 $46.25 $9.25 $7.80 -15.68%
Signal Genetics (SGNL) Aegis Capital Corp 0.85 $8.50 $10.00 $8.36 -16.40%

The IPO Buzz: Drugs, Energy and Money

The records show pharmaceutical IPOs have underperformed in today’s new-issues market. The average opening-day loss since the beginning of April is 2.82 percent.
 
Consider this: From April 1 through June 13, 2014, eight pharmaceutical IPOs were priced, according to the U.S. Securities and Exchange Commission filings. Seven of the eight attracted so little interest that they had be to be cut in size to get out the door. Their opening-day scorecard is poor.
 
Only two of the eight finished their opening day as winners. Five were losers. One was unchanged. And yes, there is that average opening-day loss of 2.82 percent.
 
From April 1 through mid-June, 51 IPOs from other sectors were priced. Their scorecard: 40 winners, nine losers, two unchanged. The average opening-day gain for all 51 was 10.64 percent.
 
“I Wanna New Drug”
Three of this week’s eight pharmaceutical IPOs are companies with stories. So you might want to put Graham and Dodd back on the bookshelf. You don’t have to be a fan of Huey Lewis and the News – and their 1984 hit “I Want a New Drug” – to take note of these companies with products in development to treat chronic kidney and gastrointestinal diseases, breast cancer and obesity.   
 
Ardelyx (ARDX – proposed) is a Fremont, California-based clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of innovative non-systemic, small molecule therapeutics that work exclusively in the gastrointestinal tract to treat cardio-renal, GI and metabolic diseases. Chronic kidney disease and irritable bowel syndrome are among the illnesses targeted by the drugs in their pipeline. (For more information, please click here: Ardelyx)
 
Syndax Pharmaceuticals (SNDX – proposed) is a Waltham, Massachusetts-based late-stage biopharmaceutical company focused on the development and commercialization of its lead product candidate, entinostat, an epigenetic therapy for treatment-resistant cancers. Entinostat was recently granted Breakthrough Therapy designation by the U.S. Food and Drug Administration based on data from Syndax on a completed randomized Phase 2b clinical trial in estrogen receptor-positive locally recurrent or metastatic breast cancer.(For more information, please click here: Syndax Pharmaceuticals)
 
ZAFGEN (ZFGN – proposed) is a Cambridge, Massachusetts-based biopharmaceutical company dedicated to improving the health and well-being of patients affected by obesity. Its lead candidate, Beloranib, is a novel first-in-class, twice-weekly subcutaneous injection being developed for the treatment of multiple indications, including obesity and hyperphagia, or insatiable life-threatening hunger and hunger-related behaviors and severe obesity in the general population. (For more information, please click here: ZAFGEN)
 
London Calling
The favorite this week is Markit – and it’s all about the money. It’s approaching $1 billion in revenue and $128.5 million in net income for the last 12 months. This financial services company has only been around for about 11 years.
 
Markit Ltd. (MRKT – proposed) is a London-based global diversified provider of financial information services. Since Markit launched its business in 2003, the company has become deeply embedded in the systems and workflows of many of its customers. It continues to become increasingly important to its customers’ operations. Markit provides pricing and reference data, indices, valuation and trading services, trade processing, enterprise software and managed services. It counts more than 3,000 institutional customers, including banks and hedge funds. (For more information, please click here: Markit Ltd.)
 
 
Hunka Hunka Burning Coal
 
OK, Elvis fans, we didn’t forget about you. (We caught your karaoke version of “Burning Love” when you thought no one noticed.) The records show energy IPOs have been hot in today’s new-issues market. There are three on this week’s calendar: One is a coal company, another is an oil and gas company in the Appalachian Basin in Pennsylvania and a third is an oil and gas company in the Permian Basin deep in the heart of Tex-Ass.
 
Consider this: From April 1 through June 13, 2014, five energy IPOs were priced. Their opening-day scorecard makes for great reading. All five finished their opening day as winners with an average opening-day gain of 18.6 percent.
 
Over the same time frame, from April through mid-June, 54 IPOs from other sectors were priced. Their scorecard showed 37 winners, 14 losers, three unchanged, and the average opening-day gain for all 54 was 8.13 percent.
 
Here are the highlights for this week’s energy offerings:
 
Eclipse Resources (ECR – proposed) is a State College, Pennsylvania-based independent exploration and production company engaged in the acquisition and development of oil and natural gas properties in the Appalachian Basin. The company has assembled a leasehold position in Eastern Ohio and the Utica Shale fairway. (For more information, please click here: Eclipse Resources)
 
Foresight Energy LP (FELP – proposed) is a St. Louis, Missouri-based limited partnership operating low-cost and high-margin bituminous thermal coal production operations in the Illinois Basin. The company plans to make cash minimum quarterly distribution of $0.3375 per unit for each whole quarter, or $1.3500 per unit on an annualized basis, to yield 6.7 percent at the mid-point of its price range. (For more information, please click here: Foresight Energy LP)
 
Viper Energy Partners LP (VNOM – proposed) is a Midland, Texas-based limited partnership formed by Diamondback to own, acquire and exploit oil and natural gas properties in North America. The company’s initial assets consist of mineral interests in oil and natural gas properties in the Permian Basin in West Texas. The Permian Basin is one of the oldest and most prolific producing basins in North America. (For more information, please click here: Viper Energy Partners LP)
 
Looking into the week of June 23, the calendar has nine IPOs so far. They are expected to raise over $900 million. But more names could pop onto the calendar by the time that Monday, June 23, rolls around.
 
Stay tuned.
 
 
Disclosure: Neither the author nor anyone else on the IPOScoop.com staff has a position in any stocks mentioned, nor do we trade or invest in IPOs. The author and IPOScoop.com staff do not issue advice, recommendations or opinions.

IPO Traffic: Week Ending June 13, 2014

  Lead Manager/ # of Price Range   Dollar SCOOP
New Filings (Proposed Symbol) Joint-Lead Managers Shares Low High Volume Ratings
Avolon Holdings Limited (AVOL) J.P. Morgan/ Morgan Stanley/ Citigroup     $100.00 n.a.
Capnia  (CAPNU) Maxim Group LLC       $23.00 n.a.
GoDaddy (TBA) Morgan Stanley/ J.P. Morgan/ Citigroup/ Barclays/ Deutsche Bank Securities/ RBC Capital Markets $100.00 n.a.
HealthEquity  (HQY) J.P. Morgan/ Wells Fargo Securities       $100.00 n.a.
Orion Engineered Carbons S.a r.l. (OEC ) Morgan Stanley/ Goldman Sachs       $300.00 n.a.
Silenseed Ltd. (RNAI) Aegis Capital Corp       $36.40 n.a.
n.a. (not available)            
             
Postponed            
None            
             
Withdrawn            
Mercury Payment Systems   (MPS) J.P. Morgan/ Barclays/ Morgan Stanley     $100.00 n.a.
Orion Engineered Carbons Holdings (TBA) Morgan Stanley/ Goldman, Sachs/ UBS Securities   $300.00 n.a.
             
New Terms            
Ambrx  (AMBX) Stifel/ Wells Fargo Securities 5.40 $12.00 $14.00 $70.20 n.a.
Amphastar Pharmaceuticals  (AMPH) Jefferies/ BMO Capital Markets/ Piper Jaffray 7.36 $10.00 $12.00 $80.96 n.a.
Ardelyx  (ARDX) Citigroup/ Leerink Partners 3.60 $13.00 $15.00 $50.40 1-Star
Eclipse Resources (ECR) Citigroup/ Goldman Sachs/ Morgan Stanley/ Barclays/ BMO Capital Market/ Deutsche Bank Securities/ KeyBanc Capital Market/ RBC Capital Markets 30.30 $27.00 $30.00 $863.55 2-Stars
Foresight Energy Partners LP (FELP) Barclays/ Citigroup/ Morgan Stanley/ J.P. Morgan/ Goldman Sachs/ Deutsche Bank Securities 17.50 $19.00 $21.00 $350.00 2-Stars
GoPro   (GPRO) J.P. Morgan/ Citigroup/ Barclays 17.80 $21.00 $24.00 $400.50 n.a.
Imprivata  (IMPR) J.P. Morgan/ Piper Jaffray 5.00 $14.00 $16.00 $75.00 n.a.
KineMed (KNMD) Feltl and Company 4.50 $6.50 $7.50 $31.50 n.a.
Kite Pharma  (KITE) Jefferies/ Credit Suisse/ Cowen and Company 6.00 $12.00 $14.00 $78.00 1-Star
Materialise NV (MTLS) Piper Jaffray/ Credit Suisse 8.00 $12.00 $14.00 $104.00 n.a.
Minerva Neurosciences (NERV) Jefferies 5.45 $10.00 $12.00 $60.00 n.a.
Parnell Pharmaceuticals Holdings   (PARN) Jefferies/ Piper Jaffray 3.60 $17.00 $19.00 $64.80 1-Star
Signal Genetics (SGNL) Aegis Capital Corp 1.15 $10.00 $12.00 $12.65 1-Star
Taggares Agriculture  (TAG) Janney Montgomery Scott/ ROTH Capital Partners 7.00 $6.00 $7.00 $45.50 n.a.
Viper Energy Partners LP (VNOM) Barclays/ Credit Suisse/ Wells Fargo Securities 5.00 $19.00 $21.00 $100.00 2-Stars
Xunlei Limited (XNET) J.P. Morgan/ Citigroup 7.32 $9.00 $11.00 $73.15 n.a.
ZAFGEN (ZFGN) Leerink Partners/ Cowen and Company 5.00 $14.00 $16.00 $75.00 1-Star
n.a. (not available)            
             
IPOs Priced Lead Shares Amount Offer Close %
Week of June 9, 2014 Manager(s) Offered Raised Price 6/13/14 Change
Abengoa Yield plc (ABY) Citigroup/ BofA Merrill Lynch 24.80 $719.20 $29.00 $37.00 27.59%
Memorial Resource Development  (MRD) Citigroup/ Barclays/ BofA Merrill Lynch/ BMO Capital Markets/ Goldman Sachs/ Raymond James/ RBC Capital Markets/ Wells Fargo Securities 42.80 $813.20 $19.00 $22.16 16.63%
Mobile Iron  (MOBL) Morgan Stanley/ Goldman Sachs/ Deutsche Bank Securitie/ Barclays 11.11 $100.00 $9.00 $10.30 14.44%
Zhaopin Ltd (ZPIN) Credit Suisse/ UBS Investment Bank 5.61 $75.74 $13.50 $15.34 13.63%
Trinseo S.A.  (TSE) Goldman Sachs/ Deutsche Bank Securities/ Citigroup/ Morgan Stanley/ Barclays/ BofA Merrill Lynch/ HSBC/ Jefferies/ Mizuho Securities/ Scotiabank/ SMBC Nikko/ Wells Fargo Securities 10.00 $190.00 $19.00 $20.20 6.32%
Nordic American Offshore (NAO) Morgan Stanley/ Credit Suisse/ J.P. Morgan Securities/ Pareto Securities AS 5.88 $94.12 $16.00 $15.50 -3.13%
Aspen Aerogels (ASPN) Barclays/ J.P. Morgan/ Citigroup 7.50 $82.50 $11.00 $10.45 -5.00%

The IPO Buzz: The IPO Train Runs on Time

The calendar for the week of June 9 lists eight IPOs, which expect to raise about $1.8 billion. Don’t look now, but June 2014 is getting off to a fast start.
 
June by the Numbers
The June calendar has produced 192 IPOs since 2001, after the Internet bubble had burst, according to U.S. Securities and Exchange Commission filings. That makes 15 IPOs an “average” June, and that number is already in the crosshairs for 2014. Last week’s calendar produced three IPOs; eight more are set for this week, and another four IPOs are on tap for the following week. That adds up to 15 – an “average” June. And yes, the world is still waiting for Alibaba to announce its pricing terms.
 
Worth noting: There are stories out there that Alibaba is pointing to August 8 – the eighth day of the eighth month. Eight is considered a lucky number in China. A double 8 – an 88 – is considered very lucky. Actually this sounds more plausible than other stories we have been hearing.
 
Dividends, Mobile Magic and Jobs
Back to this week: The IPO professionals are reportedly focusing on three deals – Abengoa Yield plc (ABY – proposed); MobileIron (MOBL – proposed) and Zhaopin Ltd. (ZPIN – proposed).
 
Abengoa Yield plc is a Brentford, UK-based dividend play in the electric utility sector. It was formed in 2013 to serve as the primary vehicle through which Abengoa will own, manage and acquire renewable energy, conventional power and electric transmission lines and other contracted revenue-generating assets, initially focused on North America (the United States and Mexico) and South America (Peru, Chile, Uruguay and Brazil) as well as Europe (Spain). Note: Starting in the third quarter of 2014, the company plans to pay a quarterly dividend that will initially be set at $0.2592 per share, or $1.04 per share on an annualized basis, to yield 4 percent, based on the mid-point of its $25-to-$27 price range. (For more information, please click here: Abengoa Yield plc)
 
MobileIron is a Mountain View, California-based company that invented a purpose-built mobile IT platform for enterprises to secure and manage mobile applications, content and devices while giving their employees a choice of device, privacy and a native user experience. Translation: MobileIron software makes it easier to work on a mobile device, whether it’s on an iPhone, an iPad, an Android or a BlackBerry. (For more information, please click here: MobileIron)
 
Zhaopin is a Beijing-based provider of an online recruitment Website and human resources services in China. It’s been described as the largest online job service in China. With over 74 million registered users, the company is the second-largest provider measured by revenues in 2013, according to the iResearch Public Data. (For more information, please click here: Zhaopin Ltd)
 
Energy and Plastics
Rounding out the list on this week’s calendar:
Aspen Aerogels (ASPN – proposed) is a Northborough, Massachusetts-based provider of high-performance aerogel insulation used mostly in large-scale energy infrastructure facilities. (For more information, please click here: Aspen Aerogels)
 
Memorial Resource Development (MRD – proposed) is a Houston-based independent natural gas and oil company focusing on the exploitation, development, and acquisition of natural gas, NGL and oil properties with most of its activity in the Terryville Complex of North Louisiana. Note this from its prospectus: “We do not anticipate declaring or providing any cash dividends to holders of our common stock in the foreseeable future.” (For more information, please click here: Memorial Resource Development)
 
Nordic American Offshore Ltd. (NAO – proposed) is a Hamilton, Bermuda-based company formed in October 2013 to acquire and operate platform supply vessels with an initial focus of operations in the North Sea. Its ships are to be used for transporting supplies and equipment to and from offshore installations such as drilling rigs. (Note: The offering is called an IPO, but some consider this a follow-on offering. Its common shares are traded on the Norwegian OTC List, an over-the-counter market that is administered by a subsidiary of the Norwegian Securities Dealers Association, under the symbol “NAO.” On May 30, 2014, the closing price of its common shares was 102 Norwegian Kroner (“NOK”) per share, which was equivalent to approximately $16.73 per share based on the Bloomberg Composite Rate of NOK5.9785 per $1.00 in effect on that date.)(For more information, please click here: Nordic American Offshore Ltd.)
 
Trinseo S.A. (TSE – proposed) is a Berwyn, Pennsylvania-based materials company engaged in the manufacture and marketing of emulsion polymers and plastics, including various specialty and technologically differentiated products. (For more information, please click here: Trinseo S.A.)
 
Looking into the week of June 16, the calendar has four IPOs so far. They are expected to raise about $1.4 billion. But more names could pop onto the calendar by the time that Monday, June 16, rolls around.
 
Stay tuned.
 
 
Disclosure: Neither the author nor anyone else on the IPOScoop.com staff has a position in any stocks mentioned, nor do we trade or invest in IPOs. The author and IPOScoop.com staff do not issue advice, recommendations
 

IPO Traffic: Week Ending June 6, 2014

  Lead Manager/ # of Price Range   Dollar SCOOP
New Filings (Proposed Symbol) Joint-Lead Managers Shares Low High Volume Ratings
CareDx  (CDNA) Piper Jaffray/ Leerink Partners/ Raymond James/ Mizuho Securities $50.00 n.a.
Cnova N.V.  (CNV) Morgan Stanley/ J.P. Morgan       $100.00 n.a.
Pfenex  (PFNX) William Blair/ JMP Securities       $74.75 n.a.
Travelport Worldwide LTD (TVPT) Morgan Stanley/ UBS Securities/ Credit Suisse/ Deutsche Bank Securities $100.00 n.a.
Vascular Biogenics   (VBLX) Deutsche Bank Securities/ Wells Fargo Securities   $75.00 n.a.
n.a. (not available)            
             
Postponed            
None            
             
Withdrawn            
None            
             
New Terms            
Abengoa Yield plc (ABY) Citigroup/ BofA Merrill Lynch 23.10 $25.00 $27.00 $600.60 2-Stars
Aspen Aerogels (ASPN) Barclays/ J.P. Morgan/ Citigroup 6.67 $14.00 $16.00 $100.00 1-Star
Century Communities (TBA) FBR/ J.P. Morgan/ Deutsche Bank Securities 4.48 $23.00 $26.00 $109.76 n.a.
Garnero Group Acquisition (GGACU) (u) EarlyBirdCapital 12.50 $10.00 $10.00 $125.00 n.a.
Markit Ltd.  (TBA) BofA Merrill Lynch/ Barclays/ Citigroup/ Credit Suisse/ Deutsche Bank Securities/ Goldman Sachs/ HSBC/ J.P. Morgan/ Morgan Stanley/ UBS Investment Bank 45.71 $23.00 $25.00 $1,096.99 3-Stars
Memorial Resource Development  (MRD) Citigroup/ Barclays/ BofA Merrill Lynch/ BMO Capital Markets/ Goldman Sachs/ Raymond James/ RBC Capital Markets/ Wells Fargo Securities 36.00 $16.00 $18.00 $612.00 1-Star
Moko Social Media Ltd  (MOKO) Northland Capital Markets 1.21 $7.50 $9.00 $10.00 n.a.
Nordic American Offshore (NAO) Morgan Stanley/ Credit Suisse/ J.P. Morgan Securities/ Pareto Securities AS 5.88 $16.00 $18.00 $100.00 N/C
Radius Health  (RDUS) Jefferies/ Cowen and Company 6.50 $8.00 $8.00 $52.00 1-Star
Signal Genetics (SGNL) Aegis Capital Corp 1.50 $10.00 $12.00 $16.50 1-Star
Syndax Pharmaceuticals (SNDX) Deutsche Bank Securities/ Jefferies 4.30 $13.00 $15.00 $60.20 n.a.
Trinseo S.A.  (TSE) Goldman Sachs/ Deutsche Bank Securities/ Citigroup/ Morgan Stanley/ Barclays/ BofA Merrill Lynch/ HSBC/ Jefferies/ Mizuho Securities/ Scotiabank/ SMBC Nikko/ Wells Fargo Securities 10.00 $17.00 $19.00 $180.00 1-Star
WL Ross Holding  (WLRHU) Deutsche Bank Securities/ BofA Merrill Lynch 40.00 $10.00 $10.00 $400.00 1-Star
Zhaopin Ltd (ZPIN) Credit Suisse/ UBS Investment Bank 5.61 $12.50 $14.50 $75.74 3-Stars
ZS Pharma  (ZSPH) J.P. Morgan/ Credit Suisse 5.00 $15.00 $17.00 $80.00 n.a.
N/C = No Call – stock traded on the Norwegian OTC List under the symbol “NAO”       
n.a. (not available)            
             
IPOs Priced Lead Shares Amount Offer Close %
Week of June 2, 2014 Manager(s) Offered Raised Price 6/6/14 Change
Arista Networks (ANET) Morgan Stanley/ Citigroup 5.25 $225.75 $43.00 $55.00 27.91%
WL Ross Holding  (WLRHU) Deutsche Bank Securities/ BofA Merrill Lynch 43.50 $435.00 $10.00 $10.15 1.50%
Radius Health  (RDUS) Jefferies/ Cowen and Company 6.50 $52.00 $8.00 $8.01 0.12%

The IPO Buzz: Why One Isn’t the Loneliest Number

Of course, there are a couple of speed bumps on summer’s IPO Highway; maybe that’s where the confusion sets in. It slows down surrounding the July 4th holiday and then closes down by mid-August ahead of the Labor Day weekend. But the floodgates are open for business the rest of the summer.
 
Since 1970, the “average” summer amounts to 82 IPOs and the “average” year amounts to 302 IPOs. The busiest summer on record, according to the U.S. Securities and Exchange Commission filings, came in 1986 when 248 of the year’s 728 IPOs were priced. That amounted to 34.1 percent of the year’s volume. The slowest summer came in 1974 when one – yes, just one – IPO was priced. The total IPO traffic in 1974 was nine. The slowest year came in 1975 when six IPOs were priced; three came to market during that summer.
 
One for the Clouds
This brings us to the present and the first week of June 2014.
 
Over the past several years, the IPO market has shut down during the Memorial Day week, and by mid-June, the bankers have hung up the “Open” sign. This year’s IPO market swings into gear sooner.
 
The action starts this week with a single offering.
 
True, there may be only one IPO on the calendar, but it is said to have the attention of the IPO players. The buzz started early. Here’s the deal:
 
Arista Networks (ANET – proposed) is a Santa Clara, California-based supplier of cloud networking solutions. The company’s solutions use software to address the needs of large-scale Internet companies, cloud service providers and next-generation data centers for enterprises.
 
Arista’s customers, according to the prospectus, “include six of the largest cloud services providers based on annual revenue, including eBay, Facebook, Microsoft and Yahoo!, financial services organizations such as Barclays, Citigroup and Morgan Stanley, and a number of media and service providers, including AOL, Comcast, Equinix, ESPN, Netflix, and Rackspace.”
 
The prospectus continued: “Our cloud networking solutions consist of our Extensible Operating System, or EOS, a set of network applications and our 10/40/100 Gigabit Ethernet switches. … Since we began shipping our products, we have grown rapidly, and according to Crehan Research, we have achieved the second-largest market share in data center 10/40/100 Gigabit Ethernet switch ports, excluding blade switching, sold in 2013.” Competitors: Cisco, Juniper, Brocade, Hewlett-Packard and Dell
 
Consider Arista’s first-quarter results:
  • For the three months ended March 31, 2014, Arista reported net income of $12.3 million, UP 86.4 percent from $6.6 million for the same period of a year ago.
  • For the three months ended March 31, 2014, Arista reported revenue of $117.2 million, UP 90.9 percent from $61.4 million for the same period of a year ago.
The deal is expected to be priced on Thursday evening, June 5, to trade on Friday morning, June 6.
 
For more information, please click here: Arista Networks
 
Looking into the second week of June, the calendar has just one IPO so far. It is expected to raise about $100 million. But more names could pop onto the calendar by the time that Monday, June 9, rolls around.
 
Stay tuned.
 
 
Disclosure: Neither the author nor anyone else on the IPOScoop.com staff has a position in any stocks mentioned, nor do we trade or invest in IPOs. The author and IPOScoop.com staff do not issue advice, recommendations or opinions.